Benzothiazinone derivatives and their use as antibacterial...

Details Benzothiazinone derivatives and their use as antibacterial... Benzothiazinone derivatives and their use as antibacterial...

2011-01-04

2011-01-04

Habte, Kahsay T (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S006000, C544S052000

Reexamination Certificate

active

07863268

ABSTRACT:
Disclosed are benzothiazin derivatives of formula (I), preparation methods therefore, and treatment methods employing such compounds as antibacterial agents in treating infectious diseases of mammals caused by bacteria, especially diseases like tuberculosis and leprosy caused by mycobacteria:wherein R1, R2, R3, R4, R5, and R6, and other variables enumerated under one or more of R1, R2, R3, R4, R5, and R6are as defined.

REFERENCES:
patent: 3522247 (1970-07-01), Cronin et al.
patent: 242567 (1993-04-01), None
patent: 3704400 (2000-09-01), None
patent: 1322551 (1993-09-01), None
patent: 0245901 (1987-11-01), None
patent: 1568697 (2005-08-01), None
patent: WO 00/51992 (2000-09-01), None
patent: WO 03/042186 (2003-05-01), None
patent: WO 2005/092872 (2005-10-01), None
patent: WO 2007/134625 (2007-11-01), None
Jan. 1, 2001 Scientific Blueprint for TB Drug Development. The Global Alliance for TB Drug Development, Inc. vol. 81 (Supp. 1) pp. 1-45.
Apr. 2008 “Confronting the scientific obstacles to global control of tuberculosis.” Douglas B. Young et al. The Journal of Clinical Investigation. vol. 118, No. 4, pp. 1255-1265.
Apr. 4, 2006 “Synthesis and antileprosy activity of some dialkyldithiocarbamates.” Vadim Makarov et al. Journal of Antimicrobial Chemotherapy vol. 57 pp. 1134-1138.
Sep. 10, 2004 “Baterial Persistence as a Phenotypic Switch.” Nathalie Q. Balaban et al. Science. vol. 305 pp. 1622-1625.
Sep. 17, 2004 “The Transcriptional Response ofMycobacterium tuberculosisto Inhibitors of Metabolism.” Helena I. M. Boshoff et al. The Journal of Biological Chemistry vol. 279 pp. 40174-40183.
Jul. 2007 “Microarray Analysis of Whole Genome Expression of IntracellularMycobacterium tuberculosis.” Waddell, Simon J. and Philip D. Butcher. Current Molecular Medicine. vol. 7 pp. 287-296.
Jan. 2004 “High content screening applied to large-scale cell biology.” Vivek C. Abraham et al. TRENDS in Biotechnology. vol. 22, No. 1, pp. 15-22.
Aug. 27, 2008 “A Fast, Fully Automated Cell Segmentation Algorithm for High-Throughput and High-Content Screening.” D. Fenistein et al. Cytometry Part A vol. 73A pp. 958-964.
Dec. 2005 “Decaprenylphosphoryl Arabinofuranose, the Donor of the D-Arabinofuranosyl Residues of Mycobacterial Arabinan, Is Formed via a Two-Step Epimerization of Decaprenylphosphoryl Ribose.” Katarina Mikusova et al. Journal of Bacteriology. vol. 187, No. 11, pp. 8020-8025.
Nov. 1995 “Biogenesis of the Mycobacterial Cell Wall and the Site of Action of Ethambutol.” Katarina Mikusova et al. Antimicrobial Agents and Chemotherapy. vol. 39, No. 11, pp. 2484-2489.
Sep. 16, 2005 “Deletion of Cg-emb in Corynebacterianeae Leads to a Novel Truncated Cell Wall Arabinogalactan, whereas Inactivation of Cg-ubiA Results in an Arabinan-deficient Mutant with a Cell Wall Galactan Core.” Luke J. Alderwick et al. The Journal of Biological Chemistry. vol. 280, No. 37, pp. 32362-32371.
2007 “Targeting the Formation of the Cell Wall Core ofM. tuberculosis.” Clifton E. Barry et al. Infectious Disorders—Drug Targets. vol. 7, No. 2, pp. 182-202.
2008 “Biosynthesis of D-arabinose in mycobacteria—a novel bacterial pathway with implications for antimycobacterial therapy.” Beata A. Wolucka The FEBS Journal vol. 275 pp. 2691-2711.
May 8, 2009 “Benzothiazinones KillMycobacterium tuberculosisby Blocking Arabinan Synthesis.” Vadim Makarov et al. Science. vol. 324 pp. 801-804.
May 8, 2009 “Benzothiazinones KillMycobacterium tuberculosisby Blocking Arabinan Synthesis.” Vadim Makarov et al. SCIENCE vol. 324 pp. 801-804.
Gheorgiu et al., Abstract of Antituberculous substances, Rev. chim., Acad. Rep. populaire Roumaine 1, No. 1, 958 (1956) XP-002958704.
Zhang, Y. et al. “Mechanisms of Drug Resistance in Mycobacterium tuberculosis” in Tuberculosis and the Tubercle Bacillus (eds. Cole. S. et al.), Chap. 8, pp. 115-140, 2005, ASM Press, Washington, D.C.

Affiliated with

Also associated with

Rating

Benzothiazinone derivatives and their use as antibacterial... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzothiazinone derivatives and their use as antibacterial..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzothiazinone derivatives and their use as antibacterial... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2694281